These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 35628654)

  • 1. The Profile of MicroRNA Expression and Potential Role in the Regulation of Drug-Resistant Genes in Doxorubicin and Topotecan Resistant Ovarian Cancer Cell Lines.
    Stasiak P; Kaźmierczak D; Jopek K; Nowicki M; Rucinski M; Januchowski R
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Profile of MicroRNA Expression and Potential Role in the Regulation of Drug-Resistant Genes in Cisplatin- and Paclitaxel-Resistant Ovarian Cancer Cell Lines.
    Kazmierczak D; Jopek K; Sterzynska K; Nowicki M; Rucinski M; Januchowski R
    Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Significance of MicroRNAs Expression in Regulation of Extracellular Matrix and Other Drug Resistant Genes in Drug Resistant Ovarian Cancer Cell Lines.
    Kazmierczak D; Jopek K; Sterzynska K; Ginter-Matuszewska B; Nowicki M; Rucinski M; Januchowski R
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTPRK Expression Is Downregulated in Drug Resistant Ovarian Cancer Cell Lines, and Especially in ALDH1A1 Positive CSCs-Like Populations.
    Świerczewska M; Sterzyńska K; Wojtowicz K; Kaźmierczak D; Iżycki D; Nowicki M; Zabel M; Januchowski R
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31027318
    [No Abstract]   [Full Text] [Related]  

  • 5. Microarray-based detection and expression analysis of new genes associated with drug resistance in ovarian cancer cell lines.
    Januchowski R; Sterzyńska K; Zawierucha P; Ruciński M; Świerczewska M; Partyka M; Bednarek-Rajewska K; Brązert M; Nowicki M; Zabel M; Klejewski A
    Oncotarget; 2017 Jul; 8(30):49944-49958. PubMed ID: 28611294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin modulates cell type-specific miRNA networks to induce cytotoxicity in ovarian cancer cells.
    Ravindran F; Mhatre A; Koroth J; Narayan S; Choudhary B
    Life Sci; 2023 Dec; 334():122224. PubMed ID: 38084671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells.
    Yoshimura A; Sawada K; Nakamura K; Kinose Y; Nakatsuka E; Kobayashi M; Miyamoto M; Ishida K; Matsumoto Y; Kodama M; Hashimoto K; Mabuchi S; Kimura T
    BMC Cancer; 2018 Nov; 18(1):1065. PubMed ID: 30396333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of
    Nowacka M; Ginter-Matuszewska B; Świerczewska M; Sterzyńska K; Nowicki M; Januchowski R
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
    Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
    Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis.
    Loginov VI; Pronina IV; Burdennyy AM; Filippova EA; Kazubskaya TP; Kushlinsky DN; Utkin DO; Khodyrev DS; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2018 Jul; 662():28-36. PubMed ID: 29631007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel microRNAs expression of patients with chemotherapy drug-resistant and chemotherapy-sensitive epithelial ovarian cancer.
    Liu L; Zou J; Wang Q; Yin FQ; Zhang W; Li L
    Tumour Biol; 2014 Aug; 35(8):7713-7. PubMed ID: 24805828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of miR-224-5p is associated with the original cisplatin resistance of ovarian papillary serous carcinoma.
    Zhao H; Bi T; Qu Z; Jiang J; Cui S; Wang Y
    Oncol Rep; 2014 Sep; 32(3):1003-12. PubMed ID: 25017423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of microRNA-30a-5p in drug-resistant and drug-sensitive ovarian cancer cell lines.
    Liu J; Wu X; Liu H; Liang Y; Gao X; Cai Z; Wang W; Zhang H
    Oncol Lett; 2016 Sep; 12(3):2065-2070. PubMed ID: 27602140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboplatin with Decitabine Therapy, in Recurrent Platinum Resistant Ovarian Cancer, Alters Circulating miRNAs Concentrations: A Pilot Study.
    Benson EA; Skaar TC; Liu Y; Nephew KP; Matei D
    PLoS One; 2015; 10(10):e0141279. PubMed ID: 26485143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of MDR genes expression and cross-resistance in eight drug resistant ovarian cancer cell lines.
    Januchowski R; Sterzyńska K; Zaorska K; Sosińska P; Klejewski A; Brązert M; Nowicki M; Zabel M
    J Ovarian Res; 2016 Oct; 9(1):65. PubMed ID: 27756418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydrotestosterone Induces Chemo-Resistance of Triple-Negative Breast MDA-MB-231 Cancer Cells Towards Doxorubicin Independent of ABCG2 and miR-328-3p.
    Al-Momany B; Hammad H; Ahram M
    Curr Mol Pharmacol; 2021; 14(5):860-870. PubMed ID: 34061013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia.
    Feng DD; Zhang H; Zhang P; Zheng YS; Zhang XJ; Han BW; Luo XQ; Xu L; Zhou H; Qu LH; Chen YQ
    J Cell Mol Med; 2011 Oct; 15(10):2164-75. PubMed ID: 21070600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNA-192-5p impacts the sensitivity of breast cancer cells to doxorubicin via targeting peptidylprolyl isomerase A.
    Zhang Y; He Y; Lu LL; Zhou ZY; Wan NB; Li GP; He X; Deng HW
    Kaohsiung J Med Sci; 2019 Jan; 35(1):17-23. PubMed ID: 30844143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of cisplatin resistance by microRNA-139-5p-independent RNF2 downregulation and MAPK inhibition in ovarian cancer.
    Chen Y; Cao XY; Li YN; Qiu YY; Li YN; Li W; Wang H
    Am J Physiol Cell Physiol; 2018 Aug; 315(2):C225-C235. PubMed ID: 29719173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-142-5p enhances cisplatin-induced apoptosis in ovarian cancer cells by targeting multiple anti-apoptotic genes.
    Li X; Chen W; Jin Y; Xue R; Su J; Mu Z; Li J; Jiang S
    Biochem Pharmacol; 2019 Mar; 161():98-112. PubMed ID: 30639456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.